Research probes pseudotumors in MoM hips

By Terry Stanton

Award-winning Young Investigator examines reasons for revision

Metal-on-metal hip resurfacing arthroplasty (MoMHRA) has undergone a resurgence as a treatment option for young and active patients with significant hip osteoarthritis, notes Young-Min Kwon, MD, PhD, FRCS, FRACS, winner of the 2011 Kappa Delta Young Investigator Award. Although 5-year survivorship rates are 95 percent or above, more attention is being paid to device failures, especially those involving abnormal periprosthetic soft-tissue masses (pseudotumor) (Fig.1).

To View Full Article You Must